# Lactose-Free Fermented Milk Production Using Lactococcus lactis NK24 and NK34 with Immune-Enhancing Effects on RAW 264.7 Cells

**Authors:** Seo-Bin Kim, Ji-Yeon Baek, Eun-Su Lee, Na-Kyoung Lee, Hyun-Dong Paik

PMC · DOI: 10.4014/jmb.2601.01014 · 2026-02-24

## TL;DR

This study shows that lactose-free fermented milk made with Lactococcus lactis strains can boost immune responses in cells, similar to known immune stimulants.

## Contribution

The study introduces new Lactococcus lactis strains (NK24 and NK34) that produce lactose-free fermented milk with immune-enhancing properties.

## Key findings

- Lactose-free fermented milk stimulated NO production and phagocytic activity in RAW 264.7 cells.
- The milk increased mRNA levels of iNOS, COX-2, and proinflammatory cytokines.
- It also promoted protein expression and phosphorylation linked to immune pathways like NF-kB and MAPK.

## Abstract

This study aimed to produce lactose-free fermented milk using probiotic Lactococcus lactis strains and to investigate the immune-enhancing effects of fermented milk. Lactose-free milk was fermented using Laticaseibacillus rhamnosus GG (LGG), L. lactis NK24, and L. lactis NK34. The pH, TA, viable lactic acid bacterial counts, and physicochemical properties of lactose-free fermented milk were recorded over 28 days under refrigeration. Each water-soluble extract of lactose-free fermented milk stimulated NO production, phagocytic activity, and induced morphological changes in RAW 264.7 cells, similar to the LPS treatment group. Additionally, the mRNA levels of inducible nitric oxide (iNOS), cyclooxygenase-2 (COX-2), and proinflammatory cytokines increased. Furthermore, each sample promoted protein expression of iNOS, and COX-2 and phosphorylation of p38, p65, JNK, and ERK. Therefore, lactose-free milk fermented by L. lactis NK24 and L. lactis NK34 can enhance the immune response via nuclear factor-kB (NF-kB) and mitogen-activated protein kinase (MAPK) activation and has the potential for development as a functional food.

## Linked entities

- **Genes:** NOS2 (nitric oxide synthase 2) [NCBI Gene 4843], COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513], CRK (CRK proto-oncogene, adaptor protein) [NCBI Gene 1398], RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970], MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599], EPHB2 (EPH receptor B2) [NCBI Gene 2048], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790]
- **Proteins:** Nos1 (nitric oxide synthase 1, neuronal), NOS2 (nitric oxide synthase 2), COX2 (cytochrome c oxidase subunit II)

## Full-text entities

- **Genes:** Cxcl15 (C-X-C motif chemokine ligand 15) [NCBI Gene 20309] {aka Il8, Scyb15, lungkine, weche}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 19225] {aka COX2, Cox-2, PES-2, PGHS-2, PHS II, PHS-2}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Pcx (pyruvate carboxylase) [NCBI Gene 18563] {aka Pc, Pcb}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 17709], Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}
- **Diseases:** bloating (MESH:C535647), cognitive decline (MESH:D003072), Inflammatory Cytokine (MESH:D000080424), cytotoxicity (MESH:D064420), LFM (MESH:D007787), diarrhea (MESH:D003967), cancers (MESH:D009369), Inflammation (MESH:D007249)
- **Chemicals:** polyvinylidene difluoride (MESH:C024865), Tween 20 (MESH:D011136), DMSO (MESH:D004121), glucose (MESH:D005947), CO2 (MESH:D002245), LPS (MESH:D008070), MTT (MESH:C070243), PC (MESH:C053518), bile acid (MESH:D001647), NO (MESH:D009614), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), EPS (-), penicillin (MESH:D010406), acetic acid (MESH:D019342), SDS (MESH:D012967), galactose (MESH:D005690), NaOH (MESH:D012972), cholesterol (MESH:D002784), NO (MESH:D009569), ethanol (MESH:D000431), water (MESH:D014867), Griess reagent (MESH:C095000), FE (MESH:D007501), disaccharide (MESH:D004187), peptides (MESH:D010455), neutral red (MESH:D009499), Lactose (MESH:D007785), lactic acid (MESH:D019344), polyacrylamide (MESH:C016679), streptomycin (MESH:D013307), monosaccharides (MESH:D009005), agar (MESH:D000362), formazan (MESH:D005562), phosphate (MESH:D010710)
- **Species:** Leptospira sp. AB (species) [taxon 103236], Homo sapiens (human, species) [taxon 9606], Lactococcus lactis (species) [taxon 1358], Mus musculus (house mouse, species) [taxon 10090], Lacticaseibacillus rhamnosus GG (strain) [taxon 568703]
- **Cell lines:** NK34 — Rattus norvegicus (Rat), Rat hepatocellular carcinoma, Cancer cell line (CVCL_1D01), Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12975499/full.md

---
Source: https://tomesphere.com/paper/PMC12975499